INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $807,268 | +14.2% | 31,971 | -4.6% | 0.00% | 0.0% |
| Q2 2023 | $707,145 | +21.8% | 33,514 | -1.6% | 0.00% | +100.0% |
| Q1 2023 | $580,484 | -16.1% | 34,046 | -1.7% | 0.00% | -50.0% |
| Q4 2022 | $691,788 | +15.1% | 34,624 | +24.1% | 0.00% | +100.0% |
| Q3 2022 | $601,000 | +9.3% | 27,898 | +0.1% | 0.00% | 0.0% |
| Q2 2022 | $550,000 | -18.0% | 27,879 | -2.4% | 0.00% | 0.0% |
| Q1 2022 | $671,000 | -13.8% | 28,553 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $778,000 | -1.0% | 28,553 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $786,000 | -3.3% | 28,553 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $813,000 | -51.6% | 28,553 | -42.1% | 0.00% | -66.7% |
| Q1 2021 | $1,679,000 | +2.3% | 49,310 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,642,000 | -14.0% | 49,310 | -17.0% | 0.00% | 0.0% |
| Q3 2020 | $1,909,000 | +35.7% | 59,394 | +16.3% | 0.00% | +50.0% |
| Q2 2020 | $1,407,000 | +62.3% | 51,076 | -5.6% | 0.00% | +100.0% |
| Q1 2020 | $867,000 | -48.2% | 54,101 | -22.8% | 0.00% | -50.0% |
| Q4 2019 | $1,673,000 | +16.6% | 70,075 | -13.9% | 0.00% | 0.0% |
| Q3 2019 | $1,435,000 | -35.7% | 81,356 | -6.7% | 0.00% | 0.0% |
| Q2 2019 | $2,232,000 | -5.7% | 87,198 | +7.0% | 0.00% | -33.3% |
| Q1 2019 | $2,368,000 | +144.9% | 81,464 | +10.5% | 0.00% | +200.0% |
| Q4 2018 | $967,000 | -53.7% | 73,721 | -28.7% | 0.00% | -50.0% |
| Q3 2018 | $2,090,000 | -10.7% | 103,376 | +4.4% | 0.00% | 0.0% |
| Q2 2018 | $2,341,000 | +5.0% | 99,003 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $2,230,000 | -25.4% | 99,003 | +3.2% | 0.00% | -33.3% |
| Q4 2017 | $2,991,000 | +19.5% | 95,932 | +19.7% | 0.00% | 0.0% |
| Q3 2017 | $2,502,000 | +1032.1% | 80,176 | +523.2% | 0.00% | – |
| Q2 2017 | $221,000 | +2.3% | 12,865 | +4.2% | 0.00% | – |
| Q1 2017 | $216,000 | +32.5% | 12,350 | 0.0% | 0.00% | – |
| Q4 2016 | $163,000 | -8.9% | 12,350 | 0.0% | 0.00% | – |
| Q3 2016 | $179,000 | +35.6% | 12,350 | -7.6% | 0.00% | – |
| Q2 2016 | $132,000 | -21.9% | 13,360 | 0.0% | 0.00% | – |
| Q1 2016 | $169,000 | -73.3% | 13,360 | -61.6% | 0.00% | -100.0% |
| Q4 2015 | $632,000 | -19.7% | 34,807 | -17.8% | 0.00% | -50.0% |
| Q3 2015 | $787,000 | +9.9% | 42,358 | +44.5% | 0.00% | +100.0% |
| Q2 2015 | $716,000 | +76.4% | 29,320 | -5.7% | 0.00% | 0.0% |
| Q3 2014 | $406,000 | -34.6% | 31,090 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $621,000 | -42.7% | 31,090 | -45.4% | 0.00% | -33.3% |
| Q1 2014 | $1,083,000 | +11.9% | 56,890 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $968,000 | +9.0% | 56,890 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $888,000 | +30.6% | 56,890 | 0.0% | 0.00% | +50.0% |
| Q2 2013 | $680,000 | – | 56,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |